Study design & setting
It was a single-blinded, randomized clinical trial (NCT05110326) conducted at the RHS Rehabilitation Centre (RHS/EC/28-06-2021-03), Islamabad, Pakistan. The study was completed within 1 year from July 2021-June 2022 and approval was taken from the research and ethical committee (REC) of the Faculty of Rehabilitation and Allied Health Sciences (with Ref# Riphah/RCRS/REC-01055) Riphah International University.